Abeona Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Abeona Therapeutics Inc inventory turnover ratio, the Abeona Therapeutics Inc 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 0.89 in the first quarter 2026, a new company high. Average inventory processing period, for the Abeona Therapeutics Inc in Mar 31 2026 quarter, has decreased to 410 days, compare to 777 days, in the Dec 31 2025 quarter.

Within Healthcare sector 324 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 0 in the fourth quarter 2025, to 1477.

ABEO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Abeona Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ABEO Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	-	-	-	-	-
Y / Y Cost of Sales Growth	-	-	-	-	-
Inventory Turnover Ratio (TTM)	0.89	0.47	0.26	-	-
ABEO's Total Ranking	# 1477	# 0	# 0	# 0	# 0
Average inventory processing period	412	776	1409	-	-
Seq. Inventory Growth	10.21 %	13.26 %	80.57 %	-	-
Seq. Cost of Sales Growth	158.24 %	113.93 %	-	-	-

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 99
Healthcare Sector	# 325
Overall Market	# 1477

Inventory Turnover Ratio Statistics
High	Average	Low
0.89	0.89	0.89
(Mar 31 2026)

ABEO Company Profile >> Back to ABEO Efficiency Comparisons >> Compare ABEO Inventory Turnover Ratio to its Competitors

Financial Statements
Abeona Therapeutics Inc 's Inventories	$ 6 Millions	Visit ABEO's Balance sheet
Abeona Therapeutics Inc 's Cost of Revenues TTM	$ 4 Millions	Visit ABEO's Income Statement
What are ABEO's Sales?		Visit ABEO's Sales by Segment

Other Inventory Turnover Ratios
Abeona Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ABEO's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ABEO's Competitors
Inventory Turnover Ratio for ABEO's Suppliers
Inventory Turnover Ratio for ABEO's Customers

You may also want to know
ABEO's Sales Growth Rates	ABEO's Pe Price to earnings ratio	ABEO's Receivables Turnover Ratio	ABEO's Stock Quote
ABEO's Net Income Growth Rates	ABEO's Ps Price to Sales ratio	ABEO's Sales per Employee	ABEO's Asset Turnover Ratio
ABEO's Net Margin	ABEO's Pb Price to Book ratio	ABEO's Financial Strength Ratios	ABEO's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Insight Molecular Diagnostics Inc	1.92	$ 0.954 Millions	$ 0 Millions
Lifeloc Technologies Inc	1.89	$ 5.323 Millions	$ 3 Millions
Glaukos Corp	1.89	$ 120.000 Millions	$ 64 Millions
Allurion Technologies Inc	1.88	$ 5.718 Millions	$ 3 Millions
Insulet Corporation	1.86	$ 840.800 Millions	$ 452 Millions
Vycor Medical Inc	1.85	$ 0.308 Millions	$ 0 Millions
Utah Medical Products Inc	1.82	$ 15.000 Millions	$ 8 Millions
Immucell Corporation	1.81	$ 16.287 Millions	$ 9 Millions
Cerus Corporation	1.80	$ 101.000 Millions	$ 56 Millions
Sunshine Biopharma Inc	1.77	$ 23.787 Millions	$ 13 Millions
Artivion Inc	1.76	$ 162.000 Millions	$ 92 Millions
Trisalus Life Sciences Inc	1.72	$ 6.000 Millions	$ 3 Millions
Iradimed Corporation	1.72	$ 19.987 Millions	$ 12 Millions
Stryker Corp	1.71	$ 9,139.000 Millions	$ 5,347 Millions
Atricure Inc	1.70	$ 134.000 Millions	$ 79 Millions
Conmed Corporation	1.70	$ 614.344 Millions	$ 362 Millions
Rigel Pharmaceuticals Inc	1.69	$ 19.818 Millions	$ 12 Millions
Quanterix Corporation	1.69	$ 80.528 Millions	$ 48 Millions
Sanuwave Health Inc	1.68	$ 10.312 Millions	$ 6 Millions
Ceribell Inc	1.68	$ 11.000 Millions	$ 7 Millions
The Cooper Companies Inc	1.67	$ 1,457.000 Millions	$ 875 Millions
Masimo Corp	1.66	$ 595.000 Millions	$ 359 Millions
Tenon Medical Inc	1.65	$ 1.617 Millions	$ 1 Millions
Haemonetics Corporation	1.65	$ 546.000 Millions	$ 331 Millions
Anteris Technologies Global Corp	1.64	$ 0.476 Millions	$ 0 Millions
Mannkind Corporation	1.64	$ 57.376 Millions	$ 35 Millions
Catheter Precision Inc	1.63	$ 0.094 Millions	$ 0 Millions
Bruker Corporation	1.63	$ 1,891.000 Millions	$ 1,158 Millions
Waters Corporation	1.63	$ 1,297.991 Millions	$ 796 Millions
Procept Biorobotics Corporation	1.63	$ 115.000 Millions	$ 70 Millions

Date modified: 2026-06-22T20:36:53+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.